Display options
Cite
Hsu C, Sikafi R, Moore-Gillon C, et al. A Case of Severe Vedolizumab-induced Liver Injury. Inflamm Bowel Dis. 2021;27(12):e148-e149doi: 10.1093/ibd/izab160.
Hsu, C., Sikafi, R., Moore-Gillon, C., Goldin, R., & Possamai, L. (2021). A Case of Severe Vedolizumab-induced Liver Injury. Inflammatory bowel diseases, 27(12), e148-e149. https://doi.org/10.1093/ibd/izab160
Hsu, Catherine, et al. "A Case of Severe Vedolizumab-induced Liver Injury." Inflammatory bowel diseases vol. 27,12 (2021): e148-e149. doi: https://doi.org/10.1093/ibd/izab160
Hsu C, Sikafi R, Moore-Gillon C, Goldin R, Possamai L. A Case of Severe Vedolizumab-induced Liver Injury. Inflamm Bowel Dis. 2021 Nov 15;27(12):e148-e149. doi: 10.1093/ibd/izab160. PMID: 34291799.
Copy Download .nbib Format: NLM
Share it on

Inflamm Bowel Dis. 2021 Nov 15;27(12):e148-e149. doi: 10.1093/ibd/izab160.

A Case of Severe Vedolizumab-induced Liver Injury.

Inflammatory bowel diseases

Catherine Hsu, Rafid Sikafi, Claudia Moore-Gillon, Robert Goldin, Lucia Possamai

Affiliations

  1. St Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.

PMID: 34291799 DOI: 10.1093/ibd/izab160

[No abstract available.]

Publication Types